얼굴용 주사제 시장 규모는 향후 수년간 빠르게 성장할 것으로 예상되며, 2029년에는 연평균 10.4%의 연평균 복합 성장률(CAGR)로 226억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 비수술적 시술에 대한 수요 증가, 용도 확대, 개인화 및 맞춤화, 신흥 시장, 헬스케어 동향, 라이프스타일 변화로 인한 것으로 보입니다. 예측 기간 중 주요 동향으로는 비수술적 시술에 대한 수요의 지속적인 증가, 개인화된 치료 접근법의 확대, 치료 효과를 높이기 위한 병용 요법에 대한 관심 증가, 최소 침습적 기술 및 장비의 부상, 자연스러운 마무리와 섬세한 마무리로 전환 등이 있습니다.
미용 시술에 대한 관심이 높아지면서 향후 수년간 얼굴용 주사제 시장의 성장을 촉진할 것으로 예상됩니다. 미용 성형은 신체의 자연적 구조에 미치는 영향을 최소화하면서 외모의 아름다움을 향상시키는 것을 목표로 하는 치료를 포함하며, 일반적으로 외래 환자 기반에서 수행되는 경우가 많고, 기존 수술보다 덜 침습적이며, 일반적으로 외래 환자 기반에서 수행됩니다. 이러한 수요는 외모에 대한 사회적 관심, 의학의 발전으로 인해 보다 안전하고 접근하기 쉬운 시술, 자기 개선과 자신감 향상에 대한 욕구가 증가함에 따라 증가하고 있습니다. 안면주사제는 보툴리눔 톡신이나 더말 필러와 같은 물질을 정확하게 주입하여 일시적으로 주름을 줄이고 특정 부위에 볼륨을 더해 얼굴 윤곽을 개선하는 미용 시술에 사용됩니다. 예를 들어 2023년 3월 영국 미용성형외과의사협회(British Association of Aesthetic Plastic Surgeons)의 보고에 따르면 2022년 영국내 미용성형 수술 건수는 2021년 대비 102% 증가한 약 3만 1,057건에 달할 것으로 예상됩니다.에 달했습니다. 이처럼 미용 성형에 대한 수요 증가가 얼굴용 주사제 시장의 성장을 촉진하고 있습니다.
얼굴용 주사제 시장의 주요 업체들은 자연스러운 외관과 지속적인 결과를 제공하는 최소침습적 미용 시술에 대한 수요를 충족시키기 위해 오래 지속되는 히알루론산(HA) 필러와 같은 제품으로 혁신을 거듭하고 있습니다. 윤곽을 강조합니다. 예를 들어 2023년 1월 Allergan plc는 JUVEDERM VOLUX XC를 출시했습니다. JUVEDERM VOLUX XC는 21세 이상의 중등도에서 중증의 윤곽 결손을 가진 사람들을 위해 턱선을 조여주도록 특별히 고안된 HA 필러로, 최대 12개월 동안 효과가 지속되며, 다운타임을 최소화하면서 자연스러운 마무리를 위해 비수술적 옵션을 원하는 환자들을 위해 비수술적 옵션을 원하는 환자들에게 매력적인 선택이 될 수 있습니다. 연구와 높은 환자 만족도를 바탕으로 한 이 필러는 성형외과 전문의가 맞춤형 치료 계획을 세울 수 있도록 도와줍니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 얼굴용 주사제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 얼굴용 주사제 시장 : 성장률 분석
- 세계의 얼굴용 주사제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 얼굴용 주사제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 얼굴용 주사제 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 얼굴용 주사제 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 보툴리눔톡신(보톡스)
- 콜라겐
- 히알루론산
- 칼슘 하이드록시아파타이트
- 폴리유산
- 폴리메타크릴산 메틸 마이크로스피어(PMMA)
- 지방 주입
- 기타 유형
- 세계의 얼굴용 주사제 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 주름의 경감
- 페이스 리프트
- 여드름흉터의 치료
- 지방 위축증 치료
- 입술 확대
- 기타 용도
- 세계의 얼굴용 주사제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 및 외래 수술 센터
- 피부과·미용 클리닉
- 기타 최종사용자
- 세계의 얼굴용 주사제 시장, 보툴리눔톡신(보톡스)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- A형 보툴리눔톡신(Botox, Dysport, Xeomin)
- B형 보툴리눔톡신(Myobloc, Neurobloc)
- 세계의 얼굴용 주사제 시장, 콜라겐의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 소 콜라겐
- 인간 콜라겐
- 합성 콜라겐
- 세계의 얼굴용 주사제 시장, 히알루론산의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 가교 히알루론산
- 비가교 히알루론산
- 세계의 얼굴용 주사제 시장, 칼슘 하이드록시아파타이트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Radiesse(칼슘 하이드록시아파타이트 기반 필러)
- 세계의 얼굴용 주사제 시장 폴리유산의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Sculptra(폴리유산계 필러)
- 세계의 얼굴용 주사제 시장, 폴리메타크릴산 메틸 마이크로스피어(PMMA)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 아르테피르(PMMA 기반 필러)
- 세계의 얼굴용 주사제 시장, 지방 주입의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 자가 지방 이식(지방흡입과 주입)
- 볼륨 회복을 위한 지방 이식
- 세계의 얼굴용 주사제 시장, 기타 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 폴리-L-젖산
- 폴리카프로락톤계 필러
- 기타 신규 주입제
제7장 지역별·국가별 분석
- 세계의 얼굴용 주사제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 얼굴용 주사제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 얼굴용 주사제 시장 : 경쟁 구도
- 얼굴용 주사제 시장 : 기업 개요
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
- Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
- Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Sinclair Pharma Plc
- Revance Therapeutics Inc.
- Suneva Medical Inc.
- Prollenium Medical Technologies
- SciVision Biotech Inc.
- Anteis S.A.
- Anika Therapeutics Inc.
- Q-Med AB
- Bloomage BioTechnology
- Medytox Inc.
- Teoxane Laboratories
- Alphaeon Corporation
- BIOPLUS CO. LTD.
- BioPolymer GmbH & Co. KG
- Bioxis Pharmaceuticals
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 얼굴용 주사제 시장 2029 : 새로운 기회를 제공하는 국가
- 얼굴용 주사제 시장 2029 : 새로운 기회를 제공하는 부문
- 얼굴용 주사제 시장 2029 : 성장 전략
제36장 부록
KSA
Facial injectables are cosmetic procedures that involve injecting substances into facial tissues to enhance features, diminish wrinkles, restore volume, or enhance overall appearance without surgery. These treatments are commonly used to address aging signs or achieve specific aesthetic goals, offering results that are temporary or semi-permanent.
The primary types of facial injectables include botulinum toxin, collagen, hyaluronic acid, calcium hydroxyapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Botulinum toxin is a neurotoxic protein used in cosmetic procedures to temporarily relax muscle activity, primarily for reducing facial wrinkles and lines. These injectables serve various purposes such as wrinkle reduction, facelifts, acne scar treatment, lipoatrophy treatment, lip enhancement, and more. They are used by different end-users including hospitals, ambulatory surgery centers, dermatology and cosmetic clinics, among others.
The facial injectable market research report is one of a series of new reports from The Business Research Company that provides facial injectable market statistics, including facial injectable industry global market size, regional shares, competitors with a facial injectable market share, detailed facial injectable market segments, market trends and opportunities, and any further data you may need to thrive in the facial injectable industry. This facial injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The facial injectable market size has grown rapidly in recent years. It will grow from $13.74 billion in 2024 to $15.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the increased aging population, growth in consumer awareness, shift in beauty standards, regulatory approvals, and advancements in injection techniques.
The facial injectable market size is expected to see rapid growth in the next few years. It will grow to $22.65 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising demand for non-surgical procedures, expanding applications, personalization and customization, emerging markets, healthcare trends, and lifestyle changes. Major trends in the forecast period include continued growth in demand for non-surgical procedures, expansion of personalized treatment approaches, increasing focus on combination therapies for enhanced outcomes, the rise of minimally invasive techniques and devices, and a shift towards natural-looking and subtle results.
The rising interest in cosmetic procedures is expected to drive the growth of the facial injectable market in the coming years. Cosmetic procedures encompass medical treatments aimed at enhancing appearance with minimal disruption to the body's natural structure, often less invasive than traditional surgeries and typically performed on an outpatient basis. This demand is increasing due to societal focus on appearance, safer and more accessible procedures enabled by medical advancements, and a growing desire for self-improvement and confidence boost. Facial injectables are used in cosmetic procedures to temporarily reduce wrinkles, add volume to specific areas, and improve facial contours through precise injection of substances such as botulinum toxin or dermal fillers. For example, in March 2023, a report from the British Association of Aesthetic Plastic Surgeons noted a 102% increase in cosmetic procedures in the UK in 2022, reaching around 31,057 procedures, compared to 2021. Thus, the rising demand for cosmetic procedures is fueling the growth of the facial injectable market.
Leading companies in the facial injectable market are innovating with products such as long-lasting hyaluronic acid (HA) fillers to meet the demand for minimally invasive aesthetic procedures offering natural-looking and enduring results. HA fillers restore volume, smooth wrinkles, and enhance facial contours by replenishing natural skin substances. For instance, in January 2023, Allergan plc introduced JUVEDERM VOLUX XC, an HA filler specifically designed to enhance jawline definition for individuals aged 21 and above with moderate to severe contour loss. Providing effects lasting up to twelve months, JUVEDERM VOLUX XC delivers natural-looking results with minimal downtime, appealing to patients seeking non-surgical options. Supported by research and high patient satisfaction, this filler enables customized treatment plans by cosmetic specialists.
In October 2022, Prollenium Medical Technologies acquired SoftFil for an undisclosed amount, expanding its product range and enhancing its position in the aesthetic medicine industry. This acquisition strengthens innovation and offers comprehensive solutions to practitioners for optimal patient outcomes. SoftFil, a France-based company, produces cosmetic products, aesthetic microcannulas, and facial injectable solutions, complementing Prollenium's portfolio.
Major companies operating in the facial injectable market are AbbVie Inc., Sanofi S.A., Ipsen Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Plc, Revance Therapeutics Inc., Suneva Medical Inc., Prollenium Medical Technologies, SciVision Biotech Inc., Anteis S.A., Anika Therapeutics Inc., Q-Med AB, Bloomage BioTechnology, Medytox Inc., Teoxane Laboratories, Alphaeon Corporation, BIOPLUS CO. LTD., BioPolymer GmbH & Co. KG, Bioxis Pharmaceuticals, Everest Pharmaceuticals
North America was the largest region in the facial injectable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the facial injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The facial injectable market consists of sales of platelet-rich plasma (PRP) injections, collagen stimulators, lip injections, and thread lifts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Facial Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on facial injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for facial injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facial injectable market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Botulinum Toxin; Collagen; Hyaluronic Acid; Calcium Hydroxyapatite; Polylactic Acid; Polymethyl-Methacrylate Microspheres (PMMA); Fat Injection; Other Types
- 2) By Application: Wrinkle Reduction; Facelift; Acne Scar Treatment; Lipoatrophy Treatment; Lip Enhancement; Other Applications
- 3) By End-User: Hospitals And Ambulatory Surgery Centers; Dermatology And Cosmetic Clinics; Other End-Users
- Subsegments:
- 1) By Botulinum Toxin: Botulinum Toxin Type A (Botox, Dysport, Xeomin); Botulinum Toxin Type B (Myobloc, Neurobloc)
- 2) By Collagen: Bovine Collagen; Human Collagen; Synthetic Collagen
- 3) By Hyaluronic Acid: Cross-linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
- 4) By Calcium Hydroxyapatite: Radiesse (Calcium Hydroxyapatite-Based Fillers)
- 5) By Polylactic Acid: Sculptra (Polylactic Acid-Based Fillers)
- 6) By Polymethyl Methacrylate Microspheres (PMMA): Artefill (PMMA-Based Fillers)
- 7) By Fat Injection: Autologous Fat Transfer (Liposuction And Injection); Fat Grafting For Volume Restoration
- 8) By Other Types: Poly-L-Lactic Acid; Polycaprolactone-Based Fillers; Other Emerging Injectable Fillers
- Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Ipsen Pharma; Galderma S.A.; Merz Pharma GmbH & Co. KGaA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Facial Injectable Market Characteristics
3. Facial Injectable Market Trends And Strategies
4. Facial Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Facial Injectable Growth Analysis And Strategic Analysis Framework
- 5.1. Global Facial Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Facial Injectable Market Growth Rate Analysis
- 5.4. Global Facial Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Facial Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Facial Injectable Total Addressable Market (TAM)
6. Facial Injectable Market Segmentation
- 6.1. Global Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Botulinum Toxin
- Collagen
- Hyaluronic Acid
- Calcium Hydroxyapatite
- Polylactic Acid
- Polymethyl-Methacrylate Microspheres (PMMA)
- Fat Injection
- Other Types
- 6.2. Global Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Wrinkle Reduction
- Facelift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Lip Enhancement
- Other Applications
- 6.3. Global Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Ambulatory Surgery Centers
- Dermatology And Cosmetic Clinics
- Other End-Users
- 6.4. Global Facial Injectable Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Botulinum Toxin Type A (Botox, Dysport, Xeomin)
- Botulinum Toxin Type B (Myobloc, Neurobloc)
- 6.5. Global Facial Injectable Market, Sub-Segmentation Of Collagen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bovine Collagen
- Human Collagen
- Synthetic Collagen
- 6.6. Global Facial Injectable Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cross-linked Hyaluronic Acid
- Non-Cross-Linked Hyaluronic Acid
- 6.7. Global Facial Injectable Market, Sub-Segmentation Of Calcium Hydroxyapatite, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Radiesse (Calcium Hydroxyapatite-Based Fillers)
- 6.8. Global Facial Injectable Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sculptra (Polylactic Acid-Based Fillers)
- 6.9. Global Facial Injectable Market, Sub-Segmentation Of Polymethyl Methacrylate Microspheres (PMMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Artefill (PMMA-Based Fillers)
- 6.10. Global Facial Injectable Market, Sub-Segmentation Of Fat Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autologous Fat Transfer (Liposuction And Injection)
- Fat Grafting For Volume Restoration
- 6.11. Global Facial Injectable Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Poly-L-Lactic Acid
- Polycaprolactone-Based Fillers
- Other Emerging Injectable Fillers
7. Facial Injectable Market Regional And Country Analysis
- 7.1. Global Facial Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Facial Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Facial Injectable Market
- 8.1. Asia-Pacific Facial Injectable Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Facial Injectable Market
- 9.1. China Facial Injectable Market Overview
- 9.2. China Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Facial Injectable Market
- 10.1. India Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Facial Injectable Market
- 11.1. Japan Facial Injectable Market Overview
- 11.2. Japan Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Facial Injectable Market
- 12.1. Australia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Facial Injectable Market
- 13.1. Indonesia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Facial Injectable Market
- 14.1. South Korea Facial Injectable Market Overview
- 14.2. South Korea Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Facial Injectable Market
- 15.1. Western Europe Facial Injectable Market Overview
- 15.2. Western Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Facial Injectable Market
- 16.1. UK Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Facial Injectable Market
- 17.1. Germany Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Facial Injectable Market
- 18.1. France Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Facial Injectable Market
- 19.1. Italy Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Facial Injectable Market
- 20.1. Spain Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Facial Injectable Market
- 21.1. Eastern Europe Facial Injectable Market Overview
- 21.2. Eastern Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Facial Injectable Market
- 22.1. Russia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Facial Injectable Market
- 23.1. North America Facial Injectable Market Overview
- 23.2. North America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Facial Injectable Market
- 24.1. USA Facial Injectable Market Overview
- 24.2. USA Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Facial Injectable Market
- 25.1. Canada Facial Injectable Market Overview
- 25.2. Canada Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Facial Injectable Market
- 26.1. South America Facial Injectable Market Overview
- 26.2. South America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Facial Injectable Market
- 27.1. Brazil Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Facial Injectable Market
- 28.1. Middle East Facial Injectable Market Overview
- 28.2. Middle East Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Facial Injectable Market
- 29.1. Africa Facial Injectable Market Overview
- 29.2. Africa Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Facial Injectable Market Competitive Landscape And Company Profiles
- 30.1. Facial Injectable Market Competitive Landscape
- 30.2. Facial Injectable Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
31. Facial Injectable Market Other Major And Innovative Companies
- 31.1. Sinclair Pharma Plc
- 31.2. Revance Therapeutics Inc.
- 31.3. Suneva Medical Inc.
- 31.4. Prollenium Medical Technologies
- 31.5. SciVision Biotech Inc.
- 31.6. Anteis S.A.
- 31.7. Anika Therapeutics Inc.
- 31.8. Q-Med AB
- 31.9. Bloomage BioTechnology
- 31.10. Medytox Inc.
- 31.11. Teoxane Laboratories
- 31.12. Alphaeon Corporation
- 31.13. BIOPLUS CO. LTD.
- 31.14. BioPolymer GmbH & Co. KG
- 31.15. Bioxis Pharmaceuticals
32. Global Facial Injectable Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Facial Injectable Market
34. Recent Developments In The Facial Injectable Market
35. Facial Injectable Market High Potential Countries, Segments and Strategies
- 35.1 Facial Injectable Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Facial Injectable Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Facial Injectable Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
